AFP and metabolic dysfunction-associated steatohepatitis: Furthermore, we compared the ROC curves of IgM-free AIM calculated from specificity and sensitivity with those of the conventional HCC biomarkers, AFP and DCP, for each liver disease related to NASH, HCV, HBV, and for all the patients.